Published in Stem Cells Dev on June 29, 2013
Targeting the Eph System with Peptides and Peptide Conjugates. Curr Drug Targets (2015) 0.84
EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal. Cancer Med (2016) 0.84
Exosome and Microvesicle-Enriched Fractions Isolated from Mesenchymal Stem Cells by Gradient Separation Showed Different Molecular Signatures and Functions on Renal Tubular Epithelial Cells. Stem Cell Rev (2017) 0.83
Promiscuous and specific recognition among ephrins and Eph receptors. Biochim Biophys Acta (2014) 0.79
Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells. Stem Cells Dev (2016) 0.77
Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models. Exp Hematol Oncol (2015) 0.77
Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal Cells mediates changes in the expression profile of stemness markers. PLoS One (2015) 0.76
The C. elegans NR4A nuclear receptor gene nhr-6 promotes cell cycle progression in the spermatheca lineage. Dev Dyn (2015) 0.75
Eph Receptor Tyrosine Kinases in Tumor Immunity. Cancer Res (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature (2010) 15.28
Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol (2005) 7.14
Eph-ephrin bidirectional signaling in physiology and disease. Cell (2008) 7.12
Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol (2002) 6.92
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells (2001) 6.86
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood (2002) 5.14
The ephrins and Eph receptors in neural development. Annu Rev Neurosci (1998) 5.07
Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation (2003) 5.07
Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci (2004) 4.22
Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci (2003) 4.10
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol (2006) 2.87
Crystal structure of an Eph receptor-ephrin complex. Nature (2002) 2.80
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol (1999) 2.60
Cell-cell signaling via Eph receptors and ephrins. Curr Opin Cell Biol (2007) 2.24
Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci (2003) 2.22
'Eph'ective signaling: forward, reverse and crosstalk. J Cell Sci (2003) 2.17
Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell (2003) 2.11
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth. Proc Natl Acad Sci U S A (2004) 2.01
Regulation of repulsion versus adhesion by different splice forms of an Eph receptor. Nature (2000) 2.00
c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J Exp Med (2001) 1.81
Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol (2009) 1.59
EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. FASEB J (2002) 1.58
PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances. Biochem J (2012) 1.56
T cell survival and function requires the c-Abl tyrosine kinase. Cell Cycle (2008) 1.51
Mesenchymal stem cells for clinical application. Vox Sang (2009) 1.50
Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev (2012) 1.46
EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem (2005) 1.46
The Eph family of receptors. Curr Opin Cell Biol (1997) 1.45
Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity. J Biol Chem (2006) 1.40
Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway. J Biol Chem (2002) 1.37
Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J Cell Sci (2002) 1.36
Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol (2006) 1.33
The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol (2008) 1.29
Efnb1 and Efnb2 proteins regulate thymocyte development, peripheral T cell differentiation, and antiviral immune responses and are essential for interleukin-6 (IL-6) signaling. J Biol Chem (2011) 1.21
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci (2011) 1.20
Genomic profiling of mesenchymal stem cells. Stem Cell Rev (2009) 1.20
Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr (2012) 1.18
Boning up on ephrin signaling. Cell (2006) 1.15
Eph/ephrin signaling in epithelial development and homeostasis. Int J Biochem Cell Biol (2008) 1.14
EphB6-null mutation results in compromised T cell function. J Clin Invest (2004) 1.11
The EphA8 receptor regulates integrin activity through p110gamma phosphatidylinositol-3 kinase in a tyrosine kinase activity-independent manner. Mol Cell Biol (2001) 1.09
EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone (2010) 1.08
EphrinB1 is essential in T-cell-T-cell co-operation during T-cell activation. J Biol Chem (2004) 1.08
Ephrin-A1 binding to CD4+ T lymphocytes stimulates migration and induces tyrosine phosphorylation of PYK2. Blood (2004) 1.06
Recent advances on T-cell regulation by receptor tyrosine kinases. Curr Opin Hematol (2005) 1.05
Abl tyrosine kinases in T-cell signaling. Immunol Rev (2009) 1.04
Ephrin B2 induces T cell costimulation. J Immunol (2003) 1.04
Ephrin-B1 is critical in T-cell development. J Biol Chem (2006) 1.00
Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. J Bone Miner Res (2009) 1.00
Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation. J Biol Chem (2003) 0.99
Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. J Biol Chem (2007) 0.98
Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis. J Leukoc Biol (2008) 0.97
Role of ephrin B2 in human retinal endothelial cell proliferation and migration. Cell Signal (2003) 0.97
A method to isolate and purify human bone marrow stromal stem cells. Methods Mol Biol (2008) 0.95
EphB6 crosslinking results in costimulation of T cells. J Clin Invest (2002) 0.93
Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. Arterioscler Thromb Vasc Biol (2003) 0.93
New insights on translational development of mesenchymal stromal cells for suppressor therapy. J Cell Physiol (2012) 0.92
Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Stem Cells Dev (2010) 0.92
EphrinB1-EphB signaling regulates thymocyte-epithelium interactions involved in functional T cell development. Eur J Immunol (2007) 0.91
Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis. Am J Physiol Cell Physiol (2007) 0.91
Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells. J Immunol (2003) 0.90
Roles for ephrins in positionally selective synaptogenesis between motor neurons and muscle fibers. Neuron (2000) 0.89
Regulated expression of the Eph-related receptor tyrosine kinase Hek11 in early human B lymphopoiesis. Blood (1997) 0.87
Ephrin-A1 suppresses Th2 cell activation and provides a regulatory link to lung epithelial cells. J Immunol (2004) 0.86
EphB receptors trigger Akt activation and suppress Fas receptor-induced apoptosis in malignant T lymphocytes. J Immunol (2011) 0.85
Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Sci (2009) 0.84
Alterations in the thymocyte phenotype of EphB-deficient mice largely affect the double negative cell compartment. Immunology (2008) 0.84
Expression and functional effects of Eph receptor tyrosine kinase A family members on Langerhans like dendritic cells. BMC Immunol (2004) 0.83
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas. Haematologica (2012) 0.82
Eph/ephrinB mediate dental pulp stem cell mobilization and function. J Dent Res (2009) 0.81
Th2-specific immunity and function of peripheral T cells is regulated by the p56Lck Src homology 3 domain. J Immunol (2010) 0.79
A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition. Eur J Immunol (2012) 0.78
The SLP-76 Src homology 2 domain is required for T cell development and activation. J Immunol (2011) 0.78
Role of nitric oxide synthesized by nitric oxide synthase 2 in liver regeneration. Liver Int (2008) 0.78
c-Abl, an additional tyrosine kinase required for T cell development and function. Cell Cycle (2008) 0.76
Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet (2004) 7.84
SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A (2003) 6.80
Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res (2003) 5.23
Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One (2006) 3.91
Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression. Nat Biotechnol (2002) 2.61
EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification. Stem Cells (2014) 2.53
Adult human dental pulp stem cells differentiate toward functionally active neurons under appropriate environmental cues. Stem Cells (2008) 2.42
Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells (2008) 2.39
Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood (2005) 2.13
The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J Cell Physiol (2009) 2.00
Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine. Stem Cells (2008) 1.99
A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest (2004) 1.71
Seminal fluid regulates accumulation of FOXP3+ regulatory T cells in the preimplantation mouse uterus through expanding the FOXP3+ cell pool and CCL19-mediated recruitment. Biol Reprod (2011) 1.70
Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One (2008) 1.60
Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol (2009) 1.59
TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells (2009) 1.47
RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res (2003) 1.46
Immunomodulatory properties of stem cells from human exfoliated deciduous teeth. Stem Cell Res Ther (2010) 1.43
Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer Res (2005) 1.40
Stem cells and periodontal regeneration. Periodontol 2000 (2006) 1.33
Implanted adult human dental pulp stem cells induce endogenous axon guidance. Stem Cells (2009) 1.24
Genomic profiling of mesenchymal stem cells. Stem Cell Rev (2009) 1.20
Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol (2009) 1.18
Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol (2009) 1.14
Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat Clin Pract Cardiovasc Med (2006) 1.14
Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis. Proc Natl Acad Sci U S A (2005) 1.13
Clinical utility of stem cells for periodontal regeneration. Periodontol 2000 (2012) 1.13
The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. J Clin Immunol (2005) 1.13
Dasatinib suppresses in vitro natural killer cell cytotoxicity. Blood (2008) 1.13
Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells (2007) 1.10
EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone (2010) 1.08
Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice. Br J Pharmacol (2012) 1.07
Mesenchymal stem cell-organized bone marrow elements: an alternative hematopoietic progenitor resource. Stem Cells (2006) 1.07
The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone (2004) 1.06
Stem cells and future periodontal regeneration. Periodontol 2000 (2009) 1.05
Mesenchymal stem cell-mediated ectopic hematopoiesis alleviates aging-related phenotype in immunocompromised mice. Blood (2008) 1.05
The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer. Immunol Cell Biol (2013) 1.04
Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines. Stem Cells Dev (2014) 1.04
Rac2-deficient mice display perturbed T-cell distribution and chemotaxis, but only minor abnormalities in T(H)1 responses. Immunol Cell Biol (2002) 1.04
Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs. J Neurosurg Spine (2012) 1.03
Characterization of bone marrow derived mesenchymal stem cells in suspension. Stem Cell Res Ther (2012) 1.03
Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment. Brain Behav Immun (2011) 1.02
Dental pulp stem cells. Methods Enzymol (2006) 1.02
Transforming growth factor-beta-mediated signaling in T lymphocytes impacts on prostate-specific immunity and early prostate tumor progression. Lab Invest (2008) 1.01
Twist-1 induces Ezh2 recruitment regulating histone methylation along the Ink4A/Arf locus in mesenchymal stem cells. Mol Cell Biol (2012) 1.01
Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. J Reprod Immunol (2009) 1.01
Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med (2012) 1.01
T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate (2006) 1.00
Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. J Bone Miner Res (2009) 1.00
NVP-BEZ235, a dual pan class I PI3 kinase and mTOR inhibitor, promotes osteogenic differentiation in human mesenchymal stromal cells. J Bone Miner Res (2010) 1.00
Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Rev (2014) 0.98
Brief report: the differential roles of mTORC1 and mTORC2 in mesenchymal stem cell differentiation. Stem Cells (2015) 0.97
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. Haematologica (2009) 0.97
Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells. Haematologica (2013) 0.97
Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia. J Cell Mol Med (2011) 0.96
Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo. Exp Hematol (2008) 0.96
Suppression of PDGF-induced PI3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion. J Mol Endocrinol (2012) 0.95
Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo. Exp Hematol (2009) 0.94
Epithelial cell rests of Malassez contain unique stem cell populations capable of undergoing epithelial-mesenchymal transition. Stem Cells Dev (2012) 0.94
EphB/ephrin-B interaction mediates adult stem cell attachment, spreading, and migration: implications for dental tissue repair. Stem Cells (2007) 0.93
Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction. J Card Fail (2013) 0.93
Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines (2007) 0.93
Proteomic characterization of mesenchymal stem cell-like populations derived from ovine periodontal ligament, dental pulp, and bone marrow: analysis of differentially expressed proteins. Stem Cells Dev (2010) 0.93
Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Stem Cells Dev (2010) 0.92
Innate immune recognition of poxviral vaccine vectors. Expert Rev Vaccines (2011) 0.92
Guanylated polymethacrylates: a class of potent antimicrobial polymers with low hemolytic activity. Biomacromolecules (2013) 0.92
A method to isolate, purify, and characterize human periodontal ligament stem cells. Methods Mol Biol (2010) 0.91
Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. Stem Cell Rev (2013) 0.91
Immunomodulatory effects of stem cells. Periodontol 2000 (2013) 0.91
Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo. J Tissue Eng Regen Med (2010) 0.90
Periodontal-ligament-derived stem cells exhibit the capacity for long-term survival, self-renewal, and regeneration of multiple tissue types in vivo. Stem Cells Dev (2014) 0.90
The role of cell surface markers and enamel matrix derivatives on human periodontal ligament mesenchymal progenitor responses in vitro. Biomaterials (2011) 0.89
Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissues. Stem Cells Dev (2010) 0.89
Human mulipotential mesenchymal/stromal stem cells are derived from a discrete subpopulation of STRO-1bright/CD34 /CD45(-)/glycophorin-A-bone marrow cells. Haematologica (2007) 0.89
Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells. Arthritis Res Ther (2010) 0.89
Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy. Int J Cardiovasc Imaging (2010) 0.88
Human Flt-3-ligand-mobilized dendritic cells require additional activation to drive effective immune responses. Exp Hematol (2007) 0.88
Effect of coating Straumann Bone Ceramic with Emdogain on mesenchymal stromal cell hard tissue formation. Clin Oral Investig (2011) 0.87
Administration of a commercial immunostimulant preparation, EcoActiva as a feed supplement enhances macrophage respiratory burst and the growth rate of snapper (Pagrus auratus, Sparidae (Bloch and Schneider)) in winter. Fish Shellfish Immunol (2003) 0.87
Intramyocardial navigation and mapping for stem cell delivery. J Cardiovasc Transl Res (2009) 0.87
Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy. JACC Cardiovasc Interv (2010) 0.87
GM-CSF is an essential regulator of T cell activation competence in uterine dendritic cells during early pregnancy in mice. J Immunol (2010) 0.87
The potential role of fowlpox virus in rational vaccine design. Expert Rev Vaccines (2006) 0.86
Lineage differentiation of mesenchymal stem cells from dental pulp, apical papilla, and periodontal ligament. Methods Mol Biol (2012) 0.86
Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells. Tissue Eng Part A (2010) 0.86
An injectable hydrogel incorporating mesenchymal precursor cells and pentosan polysulphate for intervertebral disc regeneration. Biomaterials (2013) 0.86
Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma. Clin Cancer Res (2006) 0.86
Gamma-irradiated influenza virus uniquely induces IFN-I mediated lymphocyte activation independent of the TLR7/MyD88 pathway. PLoS One (2011) 0.85
Utilising T cell receptor transgenic mice to define mechanisms of maternal T cell tolerance in pregnancy. J Reprod Immunol (2010) 0.85
Application of autologous bone marrow derived mesenchymal stem cells to an ovine model of growth plate cartilage injury. Open Orthop J (2010) 0.85
hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations. J Bone Miner Res (2007) 0.84
Isolation and characterization of mesenchymal stem cell-like cells from healthy and inflamed gingival tissue: potential use for clinical therapy. Regen Med (2012) 0.83
An ovine model of toxic, nonischemic cardiomyopathy--assessment by cardiac magnetic resonance imaging. J Card Fail (2008) 0.82
EphB4 enhances the process of endochondral ossification and inhibits remodeling during bone fracture repair. J Bone Miner Res (2013) 0.82
Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivo. Cancer Biol Ther (2010) 0.81
TGF-beta signalling and immunity in prostate tumourigenesis. Expert Opin Ther Targets (2010) 0.81
Recombinant fowlpox virus elicits transient cytotoxic T cell responses due to suboptimal innate recognition and recruitment of T cell help. Vaccine (2008) 0.81
Role of the epithelial cell rests of Malassez in the development, maintenance and regeneration of periodontal ligament tissues. Periodontol 2000 (2013) 0.80